| Original language | English (US) |
|---|---|
| Pages (from-to) | 957-958 |
| Number of pages | 2 |
| Journal | Journal of the National Cancer Institute |
| Volume | 104 |
| Issue number | 12 |
| DOIs | |
| State | Published - Jun 20 2012 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Re: Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria
Antonio C. Wolff, M. Elizabeth Hammond, Daniel F. Hayes
Research output: Contribution to journal › Letter › peer-review
14
Scopus
citations